- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Dr Reddy's Laboratories Ltd
Add to PortfolioDRRD:IN
1,692.15 INR 14.85 0.87%As of 07:05:53 ET on 05/25/2012.
Snapshot for Dr Reddy's Laboratories Ltd (DRRD)
| Open: | 1,700.10 | Day's Range: | 1,672.85 - 1,707.00 | Volume: | 215,043 | Bid: | 1,692.60 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 1,707.00 | 52wk Range: | 1,386.10 - 1,818.00 | 1-Yr Rtn: | +9.30% | Ask: | 1,692.15 |
Stock Chart for DRRD
Key Statistics for DRRD
| Current P/E Ratio (ttm) | 20.1183 |
|---|---|
| Estimated P/E (03/2013) | 17.6501 |
| Earnings Per Share (INR) (ttm) | 84.1100 |
| Est. EPS (INR) (03/2013) | 95.8720 |
| Est. PEG Ratio | 0.8134 |
| Market Cap (M INR) | 286,799.53 |
| Shares Outstanding (M) | 169.49 |
| Enterprise Value (M INR) (ttm) | 311,031.34 |
| Enterprise Value/EBITDA (ttm) | 20.14 |
| Price/Book (mrq) | 4.9949 |
| Price/Sale (ttm) | 2.9660 |
| Dividend Indicated Gross Yield | 0.8124 |
| Next Earnings Announcement | 07/20/2012 |
More DRRD Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for DRRD
- Operating
- Investing
- Financing (M/INR)
Company Profile & Key Executives for DRRD
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
| Kallam Anji ReddyChairman/Founder | G V PrasadVice Chairman/CEO |
| Saumen ChakrabortyPresident:Corporate | Umang VohraSenior VP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page